Drug discovery

Pentabind use Generative AI to design aptamers that can bind to transcription factors unlike traditional drugs. They have built the largest dataset of its kind, and can design aptamers in 20x less time and cost, with 50% improved performance compared to manual experiments.

Be part of SBC Catalyser Programme!

Spaces are limited to 10 companies per cohort. Contact Marco to get more information on our next programme in spring 2024.

Contact Marco

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.